Darade, A.R.; Lapteva, M.; Hoffmann, T.; Mandler, M.; Schneeberger, A.; Kalia, Y.N.
Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression. Pharmaceutics 2022, 14, 151.
https://doi.org/10.3390/pharmaceutics14010151
AMA Style
Darade AR, Lapteva M, Hoffmann T, Mandler M, Schneeberger A, Kalia YN.
Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression. Pharmaceutics. 2022; 14(1):151.
https://doi.org/10.3390/pharmaceutics14010151
Chicago/Turabian Style
Darade, Aditya R., Maria Lapteva, Thomas Hoffmann, Markus Mandler, Achim Schneeberger, and Yogeshvar N. Kalia.
2022. "Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression" Pharmaceutics 14, no. 1: 151.
https://doi.org/10.3390/pharmaceutics14010151
APA Style
Darade, A. R., Lapteva, M., Hoffmann, T., Mandler, M., Schneeberger, A., & Kalia, Y. N.
(2022). Effect of mRNA Delivery Modality and Formulation on Cutaneous mRNA Distribution and Downstream eGFP Expression. Pharmaceutics, 14(1), 151.
https://doi.org/10.3390/pharmaceutics14010151